A Randomized, Double-blind, Placebo Controlled Phase 3 Study of Venetoclax in Combination with Azacitidine Versus Azacitidine in Treatment Naive Subjects with Acute Myeloid Leukemia who are ineligible for Standard Induction Therapy.
- Wei, Andrew (Primary Chief Investigator (PCI))
- Kennedy, Nola (Project Manager)
Project: Research